Syndax Pharmaceuticals (SNDX) Stock Highlights

15.95 | +1.14%

2024-11-21 03:03:14

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The companys product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the bodys immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Statistics

Range Today

15.34 16.19

Volume Today 1.27M

Range 1 Year

14.97 25.34

Volume 1 Year 310.66M

Range 3 Year

11.22 29.86

Volume 3 Year 736.44M

Range 10 Year

3.39 29.86

Volume 10 Year 1.2B

Highlights

Market Capitalization 1.86B (small)

Floating Shares 85.02M

Current Price 15.95

Price To Earnings -5.84

Price To Revenue 91.01

Price To Book 5.09

Earnings Per Share -3.69

Payout Ratio 0%

Performance

Latest +1.14%

1 Month -18.62%

3 Months -21.66%

6 Months -21.39%

1 Year +4.11%

3 Years -12.6%

5 Years +132.85%

10 Years +32.92%

Benchmarks

Market Capitalization

81 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

271 / 368

Free Cashflow

262 / 352

Performance 5 years

60 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.